NEUROPEPTIDE CHANGES IN A PRIMATE MODEL (CEBUS-APELLA) FOR TARDIVE-DYSKINESIA

被引:14
作者
JOHANSSON, PE [1 ]
TERENIUS, L [1 ]
HAGGSTROM, JE [1 ]
GUNNE, L [1 ]
机构
[1] UNIV UPPSALA, DEPT PHARMACOL, S-75124 UPPSALA, SWEDEN
关键词
D O I
10.1016/0306-4522(90)90424-3
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Tardive dyskinesia has been connected with regional reductions of GABA functions in the basal ganglia. In view of the possibility that peptides are involved in neuroleptic-induced dyskinesias substance P and dynorphin A levels were measured in the basal ganglia of the Cebus apella model for tardive dyskinesia. In addition, regional glutamate decarboxylase activities, dopamine, homovanillic acid and dihydroxyphenylacetic acid levels were monitored. A significant dyskinesia-related decrease in glutamate decarboxylase activity was found in the subthalamic nucleus, the medial segment of globus pallidus and the rostral part of substantia nigra in accordance with earlier findings. Cebus monkeys with an intact GABA system (neuroleptic-treated controls without dyskinesia) showed increased levels of substance P and homovanillic acid in the caudate nucleus. The changes were confined to the caudal part of the body of the caudate and the nucleus accumbens. On the other hand, the dyskinetic monkeys, with a defective GABA system, did not demonstrate a similar substance P rise in the caudate or nucleus accumbens, but showed a depression of homovanillic acid levels in the caudal part of the body of the caudate nucleus. Dynorphin A, dopamine and dihydroxyphenylacetic acid showed no dyskinesia-related changes. In conclusion, the difference in glutamate decarboxylase activity between animals developing dyskinetic symptoms vs those who did not, was reflected by regional changes in substance P and homovanillic acid levels. © 1990.
引用
收藏
页码:563 / 567
页数:5
相关论文
共 45 条
[1]   REDUCED GLUTAMATE-DECARBOXYLASE ACTIVITY IN THE SUBTHALAMIC NUCLEUS IN PATIENTS WITH TARDIVE-DYSKINESIA [J].
ANDERSSON, U ;
HAGGSTROM, JE ;
LEVIN, ED ;
BONDESSON, U ;
VALVERIUS, M ;
GUNNE, LM .
MOVEMENT DISORDERS, 1989, 4 (01) :37-46
[2]  
BANNON MJ, 1986, J BIOL CHEM, V261, P6640
[3]  
BARANY S, 1979, RES COMMUN CHEM PATH, V25, P269
[4]   AN ION-EXCHANGE CHROMATOGRAPHY AND RADIOIMMUNOASSAY PROCEDURE FOR MEASURING OPIOID-PEPTIDES AND SUBSTANCE-P [J].
BERGSTROM, L ;
CHRISTENSSON, I ;
FOLKESSON, R ;
STENSTROM, B ;
TERENIUS, L .
LIFE SCIENCES, 1983, 33 (16) :1613-1619
[5]   ORIGIN OF SUBSTANCE-P AND GLUTAMIC-ACID DECARBOXYLASE (GAD) IN SUBSTANTIA NIGRA [J].
BROWNSTEIN, MJ ;
MROZ, EA ;
TAPPAZ, ML ;
LEEMAN, SE .
BRAIN RESEARCH, 1977, 135 (02) :315-323
[6]  
CHRISTENSSONNYLANDER I, 1986, EXP BRAIN RES, V64, P169
[7]   A GENERAL PROCEDURE FOR ANALYSIS OF PROENKEPHALIN-B DERIVED OPIOID-PEPTIDES [J].
CHRISTENSSONNYLANDER, I ;
NYBERG, F ;
RAGNARSSON, U ;
TERENIUS, L .
REGULATORY PEPTIDES, 1985, 11 (01) :65-76
[9]  
FIBIGER HC, 1984, TRENDS NEUROSCI, V7, P462
[10]   CHRONIC BLOCKADE OF DOPAMINE-RECEPTORS BY ANTI-SCHIZOPHRENIC DRUGS ENHANCES GABA BINDING IN SUBSTANTIA NIGRA [J].
GALE, K .
NATURE, 1980, 283 (5747) :569-570